| Literature DB >> 26954996 |
Tienan Feng1, Xiuling Feng2, Chenghua Jiang1, Chaogang Huang3, Baochi Liu3.
Abstract
Recent developments in the treatment of HIV-1 have improved the disease prognosis from a terminal disease to a chronic disease. The number of HIV-1-infected patients who require surgery has become more common. The main threat to HIV-1-infected patients following surgery is the development of sepsis. In this study, we collected a large number of clinical recordings of HIV-1-infected patients from two hospitals in China, specializing in HIV-1 treatment in order to summarize the risk indicators of sepsis in HIV-1-infected patients. We compared the significant risk indicators between the sepsis and non-sepsis groups. Using logistic regression based on the indicators of four separate surgery-based diseases, we generally found that low CD4 and hypoalbuminemia counts prior to surgery were the significant risk factors for developing sepsis. The morbidity of sepsis in trauma patients was approximately 10 times higher than the dysfunction group, whereas the tumor and the infection groups were approximately 1.5 and 2 times higher, respectively. Based on the comparison between the sepsis and non-sepsis groups for each surgery-based disease, we found that the severity of trauma is a critical risk factor for trauma patients; therefore, limiting the size of the wound during surgery is crucial. HIV-1-infected patients often develop postoperative sepsis due to immunodeficiency and complications due to the surgery. We hope that this study can help to reduce the risk of developing sepsis due to surgery and improve the survival rate of HIV-1-infected patients.Entities:
Mesh:
Year: 2015 PMID: 26954996 PMCID: PMC5176082 DOI: 10.1038/emi.2015.59
Source DB: PubMed Journal: Emerg Microbes Infect ISSN: 2222-1751 Impact factor: 7.163
Statistical results after the classification in term of sepsis
| Indicator | Non-sepsis | Sepsis | |
|---|---|---|---|
| 0.87 | |||
| Male | 390 (61.2%) | 247 (38.8%) | |
| Female | 100 (60.5%) | 66 (39.5%) | |
| Age | 43.8 ± 12.42 | 43.95 ± 13.58 | 0.95 |
| WBC (×109/L, bef) | 5.32 ± 2.63 | 6.12 ± 3.83 | <0.01 |
| WBC (×109/L, aft) | 6.35 ± 2.94 | 6.82 ± 3.73 | 0.16 |
| Hemoglobin (g/L, bef) | 128.25 ± 22.99 | 111.80 ± 25.99 | <0.01 |
| Hemoglobin (g/L, aft) | 118.95 ± 21.98 | 109.42 ± 55.30 | 0.03 |
| Platelet (×109/L, bef) | 185.94 ± 70.87 | 201.00 ± 110.93 | 0.07 |
| Platelet (×109/L, aft) | 197.15 ± 92.07 | 188.75 ± 110.87 | 0.44 |
| Protein (g/L, bef) | 43.87 ± 10.01 | 40.28 ± 13.66 | <0.01 |
| Protein (g/L, aft) | 42.86 ± 10.07 | 37.38 ± 11.08 | <0.01 |
| CD4 (cells/µL, bef) | 346.00 ± 221.80 | 222.71 ± 186.53 | <0.01 |
| CD4 (cells/µL, aft) | 273.23 ± 148.12 | 206.11 ± 173.97 | <0.01 |
| CD8 (cells/µL, bef) | 800.84 ± 470.63 | 662.99 ± 461.42 | <0.01 |
| CD8 (cells/µL, aft) | 686.35 ± 433.56 | 609.88 ± 351.00 | 0.18 |
| CD4 to CD8 ratio (bef) | 0.50 ± 0.40 | 0.37 ± 0.36 | <0.01 |
| CD4 to CD8 ratio (aft) | 0.47 ± 0.30 | 0.36 ± 0.29 | <0.01 |
| <0.01 | |||
| Dysfunction | 132 (75.6%) | 42 (24.4%) | |
| Infection | 200 (57.7%) | 146 (42.3%) | |
| Tumor | 131 (58.9%) | 92 (41.1%) | |
| Trauma | 27 (45.3%) | 33 (54.7%) | |
Indicators marked by ‘bef' mean they were acquired before surgery. Indicators marked by ‘aft' mean they were acquired after surgery.
Logistical regression of risk factors before operation (different operation type)
| Exp(B) 95% CI | |||||||
|---|---|---|---|---|---|---|---|
| Indicators | Bate(B) | Standard error | Wals | Exp(B) | |||
| Dysfunction | 15.847 | 0.001 | |||||
| Infection | 0.546 | 0.331 | 2.715 | 0.099 | 1.726 | 0.902 | 3.306 |
| Tumor | 0.661 | 0.348 | 3.616 | 0.057 | 1.937 | 0.980 | 3.830 |
| Trauma | 2.538 | 0.649 | 15.308 | 0.000 | 12.653 | 3.549 | 45.117 |
| WBC (×109/L, bef) | 0.092 | 0.048 | 3.651 | 0.056 | 1.096 | 0.998 | 1.204 |
| Hemoglobin (g/L, bef) | −0.021 | 0.006 | 13.008 | 0.000 | 0.979 | 0.968 | 0.990 |
| Protein (g/L, bef) | −0.003 | 0.012 | 0.049 | 0.824 | 0.997 | 0.974 | 1.021 |
| CD4 (cells/µL, bef) | −0.003 | 0.001 | 5.308 | 0.021 | 0.997 | 0.995 | 1.000 |
| CD8 (cells/µL, bef) | 0.000 | 0.000 | 0.605 | 0.437 | 1.000 | 0.999 | 1.000 |
| CD4 to CD8 ratio (bef) | −0.214 | 0.625 | 0.117 | 0.732 | 0.807 | 0.237 | 2.746 |
| Constant | 4.655 | 0.959 | 23.551 | 0.000 | 105.095 | ||
Figure 1Indicators with significant differences among the four groups.
Statistical results of operation type and sepsis condition
| Dysfunction | Infection | Tumor | Trauma | |||||
|---|---|---|---|---|---|---|---|---|
| Non-sepsis | Sepsis | Non-sepsis | Sepsis | Non-sepsis | Sepsis | Non-sepsis | Sepsis | |
| CD4 (cells/µL, bef) | 350.00 [130.00, 758.40] | 141.50 [9.75, 540.25] | 310.50 [75.70,574.90] | 177.00 [6.20, 427.20] | 329.00 [29.60, 713.00] | 162.00 [8.80, 627.00] | 329.00 [140.25, 775.60] | 333.00 [100.10,863.50] |
| CD8 (cells/µL, bef) | 760.50 [267.25, 1494.85] | 471.00 [209.50, 1593.00] | 718.00 [250.50, 1943.80] | 468.00 [104.80, 1503.00] | 665.00 [176.00, 2147.00] | 540.00 [226.40, 1580.40] | 427.00 [253.00, 1007.00] | 816.00 [301.40, 2154.60] |
| CD4CD8Ratio (bef) | 0.42 [0.11, 1.05] | 0.22 [0.03, 0.83] | 0.38 [0.09, 1.06] | 0.31 [0.02, 1.02] | 0.39 [0.06, 1.13] | 0.23 [0.02, 0.79] | 0.73 [0.32, 1.36] | 0.43 [0.13, 1.79] |
| WBC (×109/L, bef) | 4.69 [2.56, 9.93] | 5.05 [1.64, 24.11] | 5.00 [2.51, 8.75] | 5.48 [2.55, 12.68] | 4.52 [2.94, 8.88] | 4.98 [2.32, 9.73] | 6.15 [3.35, 15.84] | 5.87 [3.02, 12.84] |
| Hemoglobin (g/L, bef) | 131.00 [77.60, 169.10] | 112.60 [55.40, 170.32] | 135.00 [91.25, 158.00] | 110.00 [73.20, 144.00] | 131.50 [85.35, 156.44] | 115.00 [64.80, 153.20] | 129.00 [73.00, 160.00] | 118.00 [35.00, 155.50] |
| Platelet (×109/L, bef) | 162.50 [56.00, 323.85] | 158.00 [23.30, 508.10] | 185.50 [111.25, 335.25] | 192.00 [65.30, 477.50] | 183.00 [59.70, 340.70] | 170.00 [44.00, 336.00] | 190.00 [84.00, 283.00] | 183.00 [69.25, 398.75] |
| Protein (g/L, bef) | 43.55 [30.89, 68.57] | 37.00 [25.58, 72.24] | 44.60 [33.12, 73.46] | 37.00 [23.90, 74.70] | 41.85 [28.22, 67.40] | 39.50 [23.80, 65.88] | 35.95 [31.00, 46.80] | 40.70 [27.00, 136.00] |
| CD4 (cells/µL, aft) | 301.00 [83.70,528.00] | 87.00 [20.00, 750.00] | 177.00 [27.10, 530.60] | 208.50 [8.15, 564.55] | 275.00 [34.60, 668.00] | 153.00 [3.10, 482.30] | 508.00 [166.00, 640.00] | 460.50 [82.00, 643.00] |
| CD8 (cells/µL, aft) | 600.00 [267.90, 1441.40] | 594.00 [214.00, 1148.00] | 609.00 [160.40, 1813.00 | 612.00 [142.00, 1662.20] | 561.00 [27.27, 2253.40] | 479.00 [130.40, 1250.00] | 441.00 [427.00, 663.00] | |
| CD4CD8Ratio (aft) | 0.46 [0.21, 1.13] | 0.22 [0.06, 0.99] | 0.27 [0.07, 0.98] | 0.26 [0.03, 1.07] | 0.39 [0.11, 1.12] | 0.37 [0.03, 19.30] | 1.15 [0.25, 1.50] | 0.50 [0.24, 1.24] |
| WBC (×109/L, aft) | 6.73 [3.21, 15.73] | 7.49 [1.31, 19.78] | 5.51 [2.81, 9.35] | 5.59 [2.07, 16.30] | 5.40 [2.57, 12.22] | 5.87 [1.72, 12.99] | 3.91 [2.16, 10.14] | 6.51 [2.80, 10.78] |
| Hemoglobin (g/L, aft) | 121.40 [76.75, 154.48] | 107.25 [72.51, 147.95] | 126.00 [80.44, 153.16] | 98.10 [51.50, 143.26] | 115.00 [78.00, 147.65] | 115.00 [59.10, 142.11] | 108.80 [83.00, 139.00] | 107.00 [70.35, 154.28] |
| Platelet (×109/L, aft) | 173.00 [59.15, 378.05] | 163.00 [29.40, 431.40] | 196.00 [118.00, 401.50] | 189.00 [35.75, 476.25] | 169.00 [75.80, 493.00] | 165.00 [43.20, 370.70] | 246.00 [66.00, 472.00] | 188.50 [64.05, 396.15] |
| Protein (g/L, bef) | 40.90 [28.87, 69.28] | 33.95 [19.03, 65.03] | 42.90 [32.10, 74.09] | 36.50 [23.39, 71.68] | 39.80 [29.60, 68.43] | 34.80 [24.74, 69.26] | 41.83 [35.20, 57.40] | 35.85 [28.20, 46.40] |
Median [95% CI low, 95% CI high].